<?xml version="1.0" encoding="UTF-8"?>
<ref id="B33-cancers-10-00197">
 <label>33.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Coen</surname>
    <given-names>N.</given-names>
   </name>
   <name>
    <surname>Duraffour</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Haraguchi</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Balzarini</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>van den Oord</surname>
    <given-names>J.J.</given-names>
   </name>
   <name>
    <surname>Snoeck</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Andrei</surname>
    <given-names>G.</given-names>
   </name>
  </person-group>
  <article-title>Antiherpesvirus activities of two novel 4â€²-thiothymidine derivatives, KAY-2-41 and KAH-39-149, are dependent on viral and cellular thymidine kinases</article-title>
  <source>Antimicrob. Agents Chemother.</source>
  <year>2014</year>
  <volume>58</volume>
  <fpage>4328</fpage>
  <lpage>4340</lpage>
  <pub-id pub-id-type="doi">10.1128/AAC.02825-14</pub-id>
  <?supplied-pmid 24820089?>
  <pub-id pub-id-type="pmid">24820089</pub-id>
 </element-citation>
</ref>
